Innovating Works

PALO BIOFARMA

Activa
RESPIRE: Development of the first oral disease-modifying treatment for chronic obstructive pulmonary disease... PALO BIOFARMA tramitó un HORIZON EUROPE: HORIZON-EIC-2021-ACCELERATOROPEN-01 Palobiofarma is a Spanish biotech company with the ambition to develop new treatments for cancer and autoimmune diseases based on adenosine...
2022-10-06 - 2024-06-30 | Financiado
IMAP: Integrative mechanistic and multi omics Modelling of Antigen Presentation to predict epitope dynamic... MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV tramitó un H2020: ERC-2020-STG The immune system can patrol cell status by recognising epitopes bound to Human Leukocyte Antigen class I (HLA-I) molecules and triggering c...
2020-10-13 - 2026-03-31 | Financiado
HighLite: High performance low cost modules with excellent environmental profiles for a competitive EU PV manu... INTERUNIVERSITAIR MICROELECTRONICA CENTRUM tramitó un H2020: H2020-LC-SC3-2018-2019-2020 The HighLite project aims to substantially improve the competitiveness of the EU PV manufacturing industry by developing knowledge-based man...
2019-07-12 - 2023-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.